Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between wistar kyoto and sprague dawley rats

Psychopharmacology

Volumn 210, Issue 2, 2010, Pages 295-302

  Carr, Gregory V ^a   Lucki, I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anxiety; Defensive burying; Kappa opioid receptor; Novelty induced hypophagia; Wistar kyoto rat

Indexed keywords

2 (3,4 DICHLOROPHENYL) N METHYL N [ 1 (3 ISOTHIOCYANATOPHENYL) 2 (1 PYRROLIDINYL)ETHYL]ACETAMIDE; KAPPA OPIATE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; 2 (3,4 DICHLOROPHENYL) N METHYL N [(1) 1 (3 ISOTHIOCYANATOPHENYL) 2 (1 PYRROLIDINYL)ETHYL]ACETAMIDE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; HYPOPHAGIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STRAIN DIFFERENCE; TRANQUILIZING ACTIVITY; WISTAR KYOTO RAT; ANXIETY; DRUG EFFICACY; PSYCHOPHARMACOLOGY;

ACETAMIDES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOTHIOCYANATES; MALE; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SPECIES SPECIFICITY;

EID: 77953289933     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1832-9     Document Type: Article

References (52)

1. Ahmadiyeh N, Churchill GA, Shimomura K, Solberg LC, Takahashi JS, Redei EE (2003) X-linked and lineage-dependent inheritance of coping responses to stress. Mamm Genome 14:748-757
2. Armario A, Gavalda A, Marti J (1995) Comparison of the behavioural, and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrtaology 20:879-890
3. Bechtholt AJ, Valentino RJ, Lucki I (2008) Overlapping and distinct brain regions associated with the anxiolytic effects of chlordiazepoxide and chronic fluoxetine. Neuropsychopharmacology 33:2117-2130
4. Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ (1988) The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) 95:298-302
5. Borsini F, Podhorna J, Marazziti D (2002) Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163:121-141
6. Britton DR, Britton KT (1981) A sensitive open field measure of anxiolytic drug activity. Pharmacol Biochem Behav 15:577-582
7. Bruchas MR, Land BB, Chavkin C (2009) The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314:44-55
8. Carr GV, Bangasser DA, Bethea T, Young M, Valentino RJ, Lucki I (2010) Antidepressant-like effects of kappa opioid receptor antagonists in Wistar-Kyoto rats. Neuropsychopharmacology 35:752-763
9. Chang AC, Takemori AE, Portoghese PS (1994) 2-(3, 4-Dichlorophcnyl)-N- methyl-N-[(1S)-1-(3-isothiocyanatophcnyl)2-(1-py rrolidinyl)ethyl]acetamide: an opioid receptor affinity label that produces selective and long-lasting kappa antagonism in mice. J Med. Chem 37:1547-1549
10. Chartoff EH, Papadopoulou M, MacDonald ML, Parsegian A, Potter D, Konradi C, Carlezon WA Jr (2009) Desipramtae reduces stressactivated dynorphin expression and CREB phosphorylation in NAc tissue. Mol Pharmacol 75:704-712
11. Cooper SJ, Jackson A, Kirkham TC (1985) Endorphins and food intake: kappa opioid receptor agonists and hyperphagia. Pharmacol Biochem Behav 23:889-901
12. De Boer SF, Koolhaas JM (2003) Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 463:145-161
13. De La Garza R 2nd, Mahoney JJ 3rd (2004) A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression. Brain Res 1021:209-218
14. Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321-1330
15. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH (2008) Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 165:342-351
16. Grillon C, Levenson J, Pine DS (2007) A single dose of the selective serotonin reuptake inhibitor Citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 32:225-231
17. Gutierrez-Mariscal M, de Gortari P, Lopez-Rubalcava C, Martinez A, Joseph-Bravo P (2008) Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHcrgic neurons in anxiety. Psychoneuroendocrinology 33:198-213
18. Howard O, Carr GV, Hill TE, Valentino RJ, Lucki I (2008) Differential blockade of CRF-evoked behaviors by depletion of norepinephrine and serotonin in rats. Psychopharmacology (Berl) 199:569-582
19. Jiao X, Pare WP, Tejani-Butt S (2003) Strain differences in the distribution of dopamine transporter sites in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 27:913-919
20. Joffe RT, Bagby RM, Levitt A (1993) Anxious and nonanxious depression. Am J Psychiatry 150:1257-1258
21. Knoll AT, Carlezon WA Jr (2009) Dynorphin, stress, and depression. Brain Res 1314:56-73
22. Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA (2007) Anxiolytic-like effects of {kappa}-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323:838-845
23. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28:407-414
24. Lopez-Rubalcava C, Lucki I (2000) Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22:191-199
25. Marshall RD, Printz D, Cardenas D, Abbate L, Liebowitz MR. (1995) Adverse events in PTSD patients taking fluoxetine. Am J Psychiatry 152:1238-1239
26. McLaughlin JP, Marton-Popovici M, Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23: 5674-5683
27. McLaughlin .TP, Li S, Valdez J, Chavkin TA, Chavkin C (2006) Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 31:1241-1248
28. Merali Z, Levac C, Anisman H (2003) Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 54:552-565
29. Pardon MC, Ma S, Morilak DA (2003) Chronic cold stress sensitizes brain noradrenergic reactivity and noradrenergic facilitation of the HPA stress response in Wistar Kyoto rats. Brain Res 971:55-65
30. Pare WP (1989) Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiol Behav 46:993-998
31. Pare WP (1992) The performance of WKY rats on three tests of emotional behavior. Physiol Behav 51:1051-1056
32. Pare WP (1994) Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiol Behav 55:433-439
33. Pare WP, Kluczynski J (1997) Differences in the stress response of Wistar-Kyoto (WKY) rats from different vendors. Physiol Behav 62:643-648
34. Pearson KA, Stephen. A, Beck SG, Valentino RJ (2006) Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar-Kyoto rats. Neuropsychopharmacology 31:2449-2461
35. Pfeiffer PN, Ganoczy D, Ilgen M, Zivin K, Valenstein M (2009) Comorbid anxiety as a suicide risk factor among depressed veterans. Depress Anxiety 26:752-757
36. Ramos A, Berton O, Mormede P, Chaouloff F (1997) A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brata Res 85:57-69
37. Rittenhouse PA, Lopez-Rubalcava C, Stanwood GD, Lucki I (2002) Amplified behavioral and endocrine responses to forced swim, stress in the Wistar-Kyoto rat. Psychoneuroendocrinology 27:303-318
38. Sareen J, Cox BJ, Afifi TO, de Graaf R, Asmundson GJ, ten Have M, Stein MB (2005) Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch Gen Psychiatry 62:1249-1257
39. Servatius RJ, Jiao X, Beck KD, Pang KC, Minor TR (2008) Rapid avoidance acquisition in Wistar-Kyoto rats. Behav Brain Res 192:191-197
40. Shephard RA, Broadhurst PL (1982) Effects of diazepam and Picrotoxin on hyponeophagia in rats. Neuropharmacology 21:771-773
41. Sibille E, Sarnyai Z, Benjamin D, Gal J, Baker H, Toth M (1997) Antisense inhibition of 5-hydroxytryptarntae2a receptor induces an antidepressant-like effect in mice. Mol Pharmacol 52:1056-1063
42. Silva RM, Grossman HC, Hadjimarkou. MM, Rossi GC, Pasternak GW, Bodnar RJ (2002) Dynorphin A(l-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. J Pharmacol Exp Ther 301:513-518
43. Sipols AJ, Bayer J, Bennett R, Figlewicz DP (2002) Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats. Peptides 23:2181-2187
44. Solberg LC, Baum AE, Ahmadiyeh N, Shimomura K, Li R, Turek FW, Churchill GA, Takahashi JS, Redei EE (2004) Sex- and lineage-specific inheritance of depression-like behavior in the rat. Mamm Genome 15:648-662
45. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157:1552-1562
46. Terlecki LJ, Pinel JPJ, Treit D (1979) Conditioned and unconditioned defensive burying in the rat. Learn Motiv 10:337-350
47. Treit D (1990) A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burytag test for anxiolytics. Pharmacol Biochem Behav 36:203-205
48. Treit D, Pesold C (1990) Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action. Physiol Behav 47:365-371
49. Treit D, Pinel JP, Fibiger HC (1981) Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav 15:619-626
50. Van Bockstaele EJ, Reyes BA, Valentino RJ (2009) The locus coemleus: a key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res 1314:162-174
51. Wittmann W, Schurik E, Rosskothen I, Gaburro S, Stagewald N, Herzog H, Schwarzer C (2009) Prodynorphta-derived peptides are critical modulators of anxiety and regulate neurochcmistry and corticosterone. Neuropsychopharmacology 34:775-785
52. Ztaner SH (1994) Panic attacks precipitated by sertraline. Am J Psychiatry 151:147-148